Mycobacterium research and diagnosis
Moving in bioRxiv, eLife, Genome Medicine, Nature Microbiology and Proceedings of the National Academy of Sciences.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 10
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Mycobacterium research and diagnosis
Newest first · last 60 days
Semapimod inhibits L-leucine uptake in Mycobacterium tuberculosis, reducing bacterial load in infected mice despite no in vitro efficacy.
- Open access
Gene conversion drives over 300 diversity hotspots in M. tuberculosis, especially within virulence and antigen-related gene families, increasing genetic variation by more than tenfold.
- Open access
Tobramycin increases Mycobacterium abscessus survival by inducing whiB7, promoting persistent infection in cystic fibrosis airway conditions.
- Open access
Migration increases the genetic diversity of Mycobacterium tuberculosis complex strains in Hamburg but does not change local transmission patterns, which remain lineage-specific.
- Open access
Autodissemination stations reduce Aedes notoscriptus mosquito populations by 70% and lower Buruli ulcer cases by 83% in urban Melbourne, Australia.
- Open access
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
